As AI tools like ChatGPT become more accessible, oncology patients are increasingly using them to guide treatment decisions, often without input from their providers. This shift is raising concerns around misinformation, trust, and clinical integration, while many oncologists remain slow to adopt AI themselves.
To explore this evolving dynamic, we surveyed U.S. oncologists via SMS using Impiricus’ proprietary HCP network. The findings reveal how AI is being used by both patients and providers, and what pharma teams must do to stay relevant and supportive in this new era of tech-enabled care.
For pharma, it’s a critical moment to lead in digital innovation, education, and support.
Enter your email below to receive the full PDF
What's Included
- Frontline feedback from academic and community oncologists across the United States
- Breakdown of patient AI usage vs physician AI usage
- Challenges oncologists are facing throughout the care journey
- Oncologist support from pharma manufacturers beyond the molecule
- In depth analysis by oncology marketing leaders from Exact Sciences, BeOne Medicines, and Klick Health
- Key insights for Pharma Marketers, Medical Affairs, and Sales Teams to enhance their collaboration model with oncologists
